Advertisement 2021 is a year for vaccines and the hope of a return to normalcy. China, which was first hit by the coronavirus a year ago, just this week approved its first homegrown vaccine for general use. Officials announced the goal of inoculating 50 million high-priority people before widespread travel surrounding the Lunar New Year holiday in early February. Comparatively, more than 4.8 million people in the United States had received their first vaccine dose under Operation Warp Speed as of January 5, according to numbers from the Centers for Disease Control and Prevention. Still, millions in China are believed to have already received shots under emergency use provisions prior to regulators giving the green light to Sinopharm. For example, CanSino was authorized to vaccinate the military, including troops on peacekeeping missions traveling to places with high levels of COVID-19 spread.